Seneca Growth Capital VCT plc is a venture capital trust specializes in growth capital. It invests in emerging biotechnology companies. It prefers to invest in unquoted and quoted MedTech companies. The fund seeks to invest in the United Kingdom, IIe-de-France, Burgundy, France, European Developed Markets. It typically invests in companies with sales greater than £10 million ($11.90 million), gross margin greater than 50% and operating margin greater than 10%.
Research context
Seneca Growth Capital VCT plc appears in PyInvesting’s London Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- GBP
- Sector
- Financial Services
- Industry
- Asset Management
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Seneca Growth Capital VCT is currently in a long term uptrend where the price is trading 23.7% above its 200 day moving average.
From a valuation standpoint, the stock is 93.2% cheaper than other stocks from the Financial Services sector with a price to sales ratio of 3.6.
Seneca Growth Capital VCT's total revenue sank by 0.0% to $260K since the same quarter in the previous year.
Its net income has dropped by 0.0% to $-268K since the same quarter in the previous year.
Finally, its free cash flow fell by 161.4% to $-47K since the same quarter in the previous year.
Based on the above factors, Seneca Growth Capital VCT gets an overall score of 2/5.